In this webinar, Dr. Spangler will highlight work spanning the discovery, design, and translation of novel molecular immunotherapeutics. Her group engineers immune proteins, including cytokines, growth factors, and antibodies, to bias immune responses toward targeted disease treatment. The talk will also address persistent barriers to protein therapeutics, including delivery, acquired resistance, and toxicity, and will explore applications in cancer, autoimmune disorders, and regenerative medicine.
Key points to be discussed during the session:
- How structural and mechanistic insights can guide biomolecular engineering
- Strategies for engineering cytokines, growth factors, and antibodies to bias immune responses
- Translation of molecular immunotherapeutics for cancer, autoimmune disorders, and regenerative medicine